When was Torigen founded?

Torigen was founded in 2012 and raised its 1st funding round 5 years after it was founded.

Where is Torigen located?

Torigen is headquartered in Farmington, United States. It is registered at Farmington,Connecticut.

How many employees does Torigen have?

As of Sep 30, 2026, the latest employee count at Torigen is 22.

Is Torigen a funded company?

Torigen is a funded company, having raised a total of $20.8M across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2017.

When was the latest funding round of Torigen?

Torigen's latest funding was a $***** Series A round on Nov 16, 2022, with participation from 10 investors.

Where does Torigen rank among its competitors?

Torigen ranks 1st amongst 10 active competitors, of which 3 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was LEAH Labs, which secured $500K in Aug, 2025.

Who are the top competitors of Torigen?

Torigen's top competitors include LEAH Labs, AlsterScience and Jenga Biosciences. Among them, LEAH Labs secured the most recent funding round in August, 2025.

Torigen - 2026 Company Profile, Team, Funding & Competitors

Torigen is a series A company based in Farmington (United States), founded in 2012 by Ashley Kalinauskas. It operates as a Provider of personalized cancer immunotherapies to the veterinary market. Torigen has raised $20.8M in funding from investors like Connecticut Innovations, SoGal Ventures and Werth Ventures. The company has 10 active competitors, including 3 funded and 1 that has exited. Its top competitors include companies like LEAH Labs, AlsterScience and Jenga Biosciences.

Company Details

Provider of personalized cancer immunotherapies to the veterinary market. The company has developed autologous cancer vaccines for the treatment. The company has developed VetiVax, is a revolutionary cancer immunotherapy that uses the patient's own tumor cells to create a personalized treatment that educates the immune system to recognize the tumor as foreign.

Website: www.torigen.com/
Email ID: *****@vetivax.com
Phone Number: +1 **********
Registered Address: Farmington,Connecticut

Key Metrics

Founded Year

2012

Location

Farmington, United States

Stage

Series A

Total Funding

$20.8M in 6 rounds

Latest Funding Round

Series A, Nov 16, 2022, $*****

Investors

Connecticut Innovations & 16 more

Ranked

1^st among 10 active competitors

Employee Count

22 as on Sep 30, 2026

Similar Companies

LEAH Labs & 11 more

View Torigen's full profile

Torigen is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
TORIGEN PHARMACEUTICALS, INC. CIN: 462915380 , United States, Active	Dec 31, 1999	-	16 (As on Dec 31, 2024)	-

Torigen has raised a total funding of $20.8M over 6 rounds. Its first funding round was on 2017. Its latest funding round was a Series A round on Nov 16, 2022 for $*****. 10 investors participated in its latest round. Torigen has 17 institutional investors.

Here is the list of recent funding rounds of Torigen:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 16, 2022	5538394	Series A	3792893	8915277	6842689	2116771
Dec 06, 2021	8584330	Series A	3936777	2254859	6479270	4315458
Mar 04, 2021	9240719	Series A	7345099	2807829	9033831	5422107

Access funding benchmarks and valuations. Sign up today!

View details of Torigen's funding rounds and investors

The founders of Torigen is Ashley Kalinauskas.

Here are the details of Torigen's key team members:

Ashley Kalinauskas: Founder of Torigen.
Contact Info: 1 email address

View details of Torigen's Founder profiles and Board Members

Torigen's employee count trend

Torigen has 22 employees as of Sep 26. Here is Torigen's employee count trend over the years:

Uncover Torigen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Torigen include LEAH Labs, AlsterScience and Jenga Biosciences. Here is the list of Top 10 competitors of Torigen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Torigen 2012, Farmington (United States), Series A	Provider of personalized cancer immunotherapies to the veterinary market	$20.8M	SoGal Ventures, Everywhere & 15 others	43/100
2nd	LEAH Labs 2018, Scottsdale (United States), Seed	Developer of gene editing tools for dogs to fight against cancer	$1.27M	Ag Startup Engine, 321 Ridgeland Ventures ... & 2 others	37/100
3rd	AlsterScience 2010, Hamburg (Germany), Seed	Provider of immunotherapies for animals	-	HTGF, IFB Innovationsstarter & 2 others	26/100
4th	Jenga Biosciences 2024, Carmel (United States), Unfunded	Developer of cancer treatments for veterinary use	-	-	25/100
5th	Hastim 2003, Toulouse (France), Unfunded	Developer of immunotherapeutic treatments for humans and animals	-	-	24/100
6th	Protect Biotech Incorporation United States, Unfunded	Developer of of companion animal immunotherapy drugs	-	-	24/100
7th	Alv 2020, Oslo (Norway), Unfunded	Developer of immunotherapies for cancer treatment in dogs and cats	-	-	19/100
8th	Zander Therapeutics 2015, La Mesa (United States), Deadpooled	Developer of therapy for cancer and autoimmune diseases in animals	-	-	18/100
9th	Vet Therapeutics 2009, Del Mar (United States), Acquired	Developer of antibody-based therapies to treat cancer in companion animals	-	HHS	18/100
10th	Entest BioMedical 2008, La Mesa (United States), Deadpooled	Developer of immunotherapeutics for canines with cancer and autoimmune disorders	-	-	18/100